| Frequentist versus Bayesian clinical trials D Teira Philosophy of Medicine, 255-297, 2011 | 36 | 2011 |
| Causality, impartiality and evidence-based policy D Teira, J Reiss Mechanism and causality in biology and economics, 207-224, 2013 | 35 | 2013 |
| Facts, norms and expected utility functions S Jallais, PC Pradier, D Teira History of the Human Sciences 21 (2), 45-62, 2008 | 31 | 2008 |
| Disease-mongering through clinical trials M González-Moreno, C Saborido, D Teira Studies in History and Philosophy of Science Part C: Studies in History and …, 2015 | 28 | 2015 |
| Milton Friedman, the statistical methodologist D Teira History of political economy 39 (3), 511-528, 2007 | 19 | 2007 |
| On the impartiality of early British clinical trials D Teira Studies in History and Philosophy of Science Part C: Studies in History and …, 2013 | 18 | 2013 |
| A positivist tradition in early demand theory DT Serrano Journal of Economic Methodology 13 (1), 25-47, 2006 | 16 | 2006 |
| A contractarian solution to the experimenter’s regress D Teira Philosophy of science 80 (5), 709-720, 2013 | 15 | 2013 |
| Filosofía de las ciencias sociales JF Álvarez Álvarez, M Jiménez Buedo, D Teira Serrano, ... | 15 | 2013 |
| The Politics of Positivism: Disinterested Predictions from interested agents D Teira, JZ Bonilla The Methodology of Positive Economics: reflections on the Milton Friedman …, 2009 | 14* | 2009 |
| On the normative dimension of the St. Petersburg paradox D Teira Studies in History and Philosophy of Science Part A 37 (2), 210-223, 2006 | 14 | 2006 |
| Frank H. Knight le risque comme critique de l'économie politique PC Pradier, DT Serrano Revue de synthèse 121 (1), 79-116, 2000 | 14 | 2000 |
| Is the genie out of the bottle? Digital platforms and the future of clinical trials N Tempini, D Teira Economy and Society 48 (1), 77-106, 2019 | 12 | 2019 |
| Blinding and the non-interference assumption in medical and social trials D Teira Philosophy of the social sciences 43 (3), 358-372, 2013 | 12 | 2013 |
| Rules versus standards: what are the costs of epistemic norms in drug regulation? M Andreoletti, D Teira Science, Technology, & Human Values 44 (6), 1093-1115, 2019 | 9 | 2019 |
| What was fair in actuarial fairness? AJH Martínez, D Teira, PC Pradier | 9* | 2016 |
| Testing oncological treatments in the era of personalized medicine D Teira Philosophy of Molecular Medicine, 2016 | 9 | 2016 |
| ¿ Ética o Economía? Philippe Van Parijs y la renta básica D Teira Serrano Isegoría, 159-172., 2003 | 9 | 2003 |
| Statistical evidence and the reliability of medical research D Teira, M Andreoletti The Routledge Handbook of Philosophy of Medicine, 2016 | 8* | 2016 |
| Lo uno y lo múltiple. La estructura de la explicación económica en Walras y Marshall D Teira Ciencia económica y Economía de la Ciencia, 240-267, 2001 | 7* | 2001 |
